Zhongying Cao

Suite 902, Changtai Plaza, 2889 Jinke Road
Pudong, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB Inhibitors.

Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB Inhibitors.

Journal: Journal of medicinal chemistry

Published: November 12, 2025

Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity.

Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity.

Journal: Journal of medicinal chemistry

Published: January 09, 2025

Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform.

Discovery of macrocyclic CDK2/4/6 inhibitors with improved potency and DMPK properties through a highly efficient macrocyclic drug design platform.

Journal: Bioorganic chemistry

Published: January 24, 2024

Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach.

Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach.

Journal: Bioorganic & medicinal chemistry

Published: December 06, 2023

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor.

Journal: Chemical science

Published: October 14, 2022

Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the De Novo DNA Methyltransferase DNMT3B and Subsequent Transport to the Cytoplasm for K48-Linked Polyubiquitination.

Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the De Novo DNA Methyltransferase DNMT3B and Subsequent Transport to the Cytoplasm for K48-Linked Polyubiquitination.

Journal: Journal of virology

Published: September 08, 2018

NAC1 Potentiates Cellular Antiviral Signaling by Bridging MAVS and TBK1.

NAC1 Potentiates Cellular Antiviral Signaling by Bridging MAVS and TBK1.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 09, 2018

MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction.

MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction.

Journal: The Journal of biological chemistry

Published: July 07, 2017

Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection.

Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection.

Journal: Journal of innate immunity

Published: October 15, 2016

Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.

Methylcrotonoyl-CoA carboxylase 1 potentiates RLR-induced NF-κB signaling by targeting MAVS complex.

Journal: Scientific reports

Published: April 22, 2016

Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway.

Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: April 20, 2016

Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.

Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.

Journal: Scientific reports

Published: August 13, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026